2nd Young Scientist Cancer Congress 2024 (YS2C)

2nd Young Scientist Cancer Congress 2024 (YS2C) New translational approaches in cancer therapy October 10 & 11, 2024 – Montpellier France The postdoc association of the Cancer Research Center of Toulouse was created in 2022 by Benoît Aliaga, Chloé Bessière...

3D-GATA2

3D-GATA2. Individuals with heterozygous germline GATA2 mutation present with a rare and highly heterogeneous syndrome. Prognosis is dismal, especially because of immunodeficiency and an exceedingly high risk of myelodysplastic syndrome and leukemia. While most...

1st Young Scientist Cancer Congress (YS2C)

1st Young Scientist Cancer Congress (YS2C) New research strategies for cancer therapy – from bench to bedside October 05, 2023 – Toulouse France The CRCT postdocs association was created in 2022 by Benoît Aliaga, Chloé Bessière and Steffen Fuchs. It gathers the...

Biolican

Biolican : To develop new technological approaches for the detection of new circulating biomarkers for the management of lung cancer. In routine clinical practice, physicians rely heavily on tumour biopsy to make a diagnosis of cancer. This tumour sample also...

LungPredict

LungPredict A collaboration in Toulouse, France, between Pierre Fabre Research Institute, the University Cancer Institute and the Cancer Research Center aims to collect and integrate data to improve and personalize lung cancer therapies. The ultimate goal of the...

MSrGB

MSrGB​: Metabolic Shift in radioresistance of GlioBlastoma Study of the involvement of metabolic shift in the radioresistance of glioblastoma stem cells: validation on blood samples and metabolic imaging of patients treated for glioblastoma in primary diagnosis...

Pin It on Pinterest